Article Versions Notes

Foroutan A, Haghshenas S, Bhai P, Levy MA, Kerkhof J, McConkey H, Niceta M, Ciolfi A, Pedace L, Miele E, et al. Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome. International Journal of Molecular Sciences. 2022; 23(3):1815. https://doi.org/10.3390/ijms23031815

Foroutan, Aidin, Sadegheh Haghshenas, Pratibha Bhai, Michael A. Levy, Jennifer Kerkhof, Haley McConkey, Marcello Niceta, Andrea Ciolfi, Lucia Pedace, Evelina Miele, and et al. 2022. "Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome" International Journal of Molecular Sciences 23, no. 3: 1815. https://doi.org/10.3390/ijms23031815

Foroutan, A., Haghshenas, S., Bhai, P., Levy, M. A., Kerkhof, J., McConkey, H., Niceta, M., Ciolfi, A., Pedace, L., Miele, E., Genevieve, D., Heide, S., Alders, M., Zampino, G., Merla, G., Fradin, M., Bieth, E., Bonneau, D., Dieterich, K., ... Lebre, A.-S. (2022). Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome. International Journal of Molecular Sciences, 23(3), 1815. https://doi.org/10.3390/ijms23031815